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Understanding the mechanisms underlying neuronal fate determination will provide important insights into
brain development and regenerative approaches to neurological diseases. Now in Cell Stem Cell, Masser-
dotti et al. (2015) use neuronal conversion of astrocytes to dissect transcriptional mechanisms of fate deter-
mination and identify circuits that mediate cellular identity.During brain development, neuronal fate
and diversity are established under tight
control of precise transcriptional pro-
grams. Complementary transcriptional
and epigenetic factors regulate gene
expression programs responsible for
maintaining neural progenitors and for
specification and maturation of neurons
and glia. Genetic studies in animals sug-
gest that some proneural genes, such as
Ascl1, neurogenin, and NeuroD, are
necessary and sufficient to initiate
neuronal lineage development and pro-
mote generation of progenitors, which
then differentiate into neurons with
distinct identities (Martynoga et al.,
2012). However, the precise molecular
mechanisms that establish neuronal fate
and diversity at the transcriptional and
epigenetic levels are incompletely under-
stood. Furthermore, studying cell fate
determination at the molecular level in
in vivo models presents significant tech-
nical challenges. Cellular reprogram-
ming—rewiring the epigenetic and tran-
scriptional network of one cell state to
that of a different cell type—offers a prime
opportunity to surmount this issue and
investigate the molecular underpinnings
of cell fate determination. In this issue of
Cell Stem Cell, Masserdotti et al. (2015)
perform direct in vitro reprogramming of
postnatal astrocytes into neurons by acti-
vation of Neurog2 or Ascl1 to identify mo-
lecular mechanisms underlying neuronal
cell fate determination.
Fibroblasts can be directly converted
to neurons by overexpression of defined
transcription factors and miRNAs (Yang
et al., 2011). Likely because of their neu-
roectodermal origin, astrocytes can be
reprogrammed into functional neurons
in vitro and in vivo with simple combina-tions of factors (e.g, Pax6, Neurog2,
Ascl1, Dlx2, and NeuroD1) (Heins et al.,
2002; Berninger et al., 2007; Heinrich
et al., 2010; Guo et al., 2014). Further-
more, forced expression of a single fac-
tor in astrocytes induces glutamatergic
(Neurog2) or GABAergic (Ascl1) neurons
(Heinrich et al., 2010). These distinct
reprograming approaches to induce
discrete neuronal fates provide in vitro
models to identify target genes in
neuronal fate and subtype specification
within the same transcriptional back-
ground, and Masserdotti et al. (2015)
now leverage these approaches to
delineate mechanisms underlying fate
determination.
The authors first assessed reprogram-
ming of proliferating astrocytes isolated
from early postnatal mouse cerebral cor-
tex. Neurog2 and Ascl1 were fused to
the modified estrogen receptor ligand-
binding domain ERT2 to enable their acti-
vation in a 4-hydroxy-tamoxifen (OHT)-
dependent manner. Neurog2 and Ascl1
elicited neuronal reprogramming with
similar efficiency. However, transcrip-
tomic analyses of transduced astrocytes
after OHT treatment revealed that
Neurog2 and Ascl1 rapidly induced
distinct transcriptional programs during
reprogramming. Further analyses identi-
fied a small subset of target genes com-
mon for both factors, including Insm1,
NeuroD4, Prox1, and Sox11. The crucial
roles of these genes in neuronal reprog-
ramming were confirmed by miRNA
knockdown studies. The authors also
found that NeuroD4 combined with
Insm1, Prox1, or Sox11 efficiently elicits
neuronal conversion of astrocytes
(Figure 1). Importantly, co-expression of
NeuroD4 plus Insm1 converted bothCell Stemmouse embryonic fibroblasts and human
astrocytes to bIII-tubulin-positive cells.
Thus, the potential of these factors for
neuronal reprogramming does not seem
to be cell-type- or species-specific.
Early postnatal astrocytes are plastic
and proliferative, which might facilitate
their reprogramming into neurons, and
can form self-renewing and multipotent
neurospheres, although this potential
declines to zero during the second
week of life (Laywell et al., 2000). The au-
thors therefore next assessed neuronal
reprogramming of astrocytes that had
been maintained in culture to mimic post-
natal maturation. Delayed induction of
Neurog2 or Ascl1 (6 days after passaging
astrocytes in culture) lowered reprogram-
ming efficiency considerably, suggesting
that prolonged culture renders astrocytes
more resistant to neuronal reprogram-
ming. Consistently, NeuroD4 was the
only Neurog2 target gene upregulated
following delayed induction of Neurog2
in astrocytes maintained in culture for 6
or 8 days, and this upregulation was
much lower than that observed during
Neurog2 induction in early cultured astro-
cytes. Neurog2 was significantly en-
riched on several of its downstream tar-
gets (e.g., NeuroD1, NeuroD4, Prox1,
and Sox11) during early induction but
much less so during delayed induction,
suggesting that the chromatin state at
those loci changed during prolonged cul-
ture. Indeed, H4K20me3, a late hetero-
chromatin marker associated with tran-
scription repression, was found to be
enriched on NeuroD4 in astrocytes that
had been maintained in culture. Thus,
continued culture renders astrocytes re-
fractory to neuronal reprogramming.
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Figure 1. Transcriptional Mechanisms Underlying Neuronal Reprogramming of Astrocytes
In astrocytes during early culture periods, REST binds to the NeuroD4 locus and suppresses its expression. Upon activation of Neurog2, Neurog2 competes and
replaces REST for binding to the NeuroD4 locus, leading to increased NeuroD4 expression and, together with other proneural factors (such as Insm1, Prox1, or
Sox11), the conversion of astrocytes to neurons. In astrocytes during prolonged cultures, chromatin modification plus some unknown factors repress NeuroD4
expression, making it unresponsive to Neurog2 and its induced neuronal reprogramming. However, exogenously introducing NeuroD4 plus other proneural fac-
tors help to bypass this blockade, converting astrocytes in prolonged culture conditions to neurons.
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downstream genes could bypass the
epigenetic barrier imposed on neuronal
reprogramming. Strikingly, expression
of either NeuroD4 or Neurog2, in com-
bination with Insm1, Prox1, or Sox11,
enabled neuronal reprogramming (Fig-
ure 1), suggesting that glial fate of astro-
cytes maintained in culture can be
rewired.
RE-1-silencing transcription factor
(REST) orchestrates astroglial differentia-
tion (Hirabayashi and Gotoh, 2010) and
represses expression of neuronal genes
in non-neuronal cells, modifying the
epigenetic status of its target genes. The
authors showed that REST is expressed
at similar levels in astrocytes before and
after prolonged culturing and that it binds
to NeuroD1/4 loci. However, only in early
cultures did Neurog2 activation signifi-
cantly reduce REST binding to these
loci. This finding may explain why delayed
induction of Neurog2 impaired neuronal
reprogramming, and it suggests that
removing REST expression might facili-
tate Neurog2-mediated reprogramming2 Cell Stem Cell 17, July 2, 2015 ª2015 Elsevof astrocytes in prolonged culture. To
test this idea, the authors cultured post-
natal astrocytes from mice homozygous
for a conditional allele of REST, in which
Cre-mediated recombination results in
expression of a truncated REST that
cannot bind to its target genes. Upon
conditionally deleting REST in astrocytes
cultured for different times, they found
that REST deletion only in early cultures
increased NeuroD4 expression and
rescued neuronal reprogramming after
delayed induction of Neurog2. These find-
ings suggest that NeuroD4 is repressed
by REST in astrocytes during early cul-
ture, where Neurog2 may compete for or
replace its binding (Figure 1). After pro-
longed culture, however, REST is no
longer required to silence NeuroD4, or
other factors are also involved in the
repression.
Taken together, the findings of Mas-
serdotti et al. (2015) provide proof of
concept that direct reprogramming may
be a model for studying neuronal fate
determination in culture. They showed
similarities in gene regulation duringier Inc.in vivo neuronal development and
in vitro direct neuronal reprogramming.
Further analysis of direct reprogramming
processes might deepen our under-
standing of neural development in vivo.
In an earlier study (Guo et al., 2014),
NeuroD1 expression directly reprog-
rammed cultured human cortical astro-
cytes to functional neurons. In vivo,
NeuroD1 directly converts reactive glial
cells (astrocytes and NG2 cells) to func-
tional neurons after brain injury and in a
mouse model of Alzheimer’s disease
(Guo et al., 2014). Interestingly, in the
current study, NeuroD1 was also identi-
fied as a downstream target of Neurog2.
Since in vitro culture systems do not fully
replicate in vivo conditions, in vitro find-
ings must be applied cautiously to the
in vivo situation. However, the similarities
between in vitro results in the current
study and previous in vivo findings sug-
gest that transcriptional analysis of direct
reprogramming might be useful for
understanding the mechanisms underly-
ing direct reprogramming of other cell
types, such as subtypes of neurons
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neurons), cardiomyocytes, and hepato-
cytes, and will facilitate development of
in vivo cell fate conversion as a therapeu-
tic strategy for neurological diseases and
other disorders.
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Eliminating hematopoietic stem cells (HSCs) with DNA damage is necessary to maintain the homeostasis
of HSCs, but the mechanisms underlying this apoptotic elimination are unclear. Now in Cell Stem Cell,
Yamashita et al. (2015) show that Aspp1 coordinates with p53 to protect HSC pool integrity, guarding against
hematological malignancies.Tissue-specific stem cells, including
hematopoietic stem cells (HSCs), are
long-lived, often quiescent cells with self-
renewal properties that maintain organ ho-
meostasis.Althoughquiescence is thought
to protect cells from some endogenous
stresses, it also presents challenges for
the cells in terms of maintaining genomic
integrity. Damaged DNA accumulates
in quiescent HSCs because they are ob-
liged to use error-prone non-homologous
recombination mechanism (also called
non-homologous end joining, or NHEJ) to
repair their damaged DNA. In contrast,
cycling HSCs repair DNA damage via
error-proof homologous recombination
(HR), but DNA replication also generates
random mutations. Hence, regardless of
the proliferation status of HSCs, there
must be mechanisms that can effectively
eliminate damaged cells to prevent hema-
tological malignancies. The tumor sup-
pressor p53 is known to be involved in
DNA-damage-induced apoptosis in both
humanandmouseHSCs,but little is known
about how this property of p53 is gated inresponse to diverse forms of genotoxic
stress to control HSC viability or elimina-
tion. In this issue of Cell Stem Cell, Yama-
shita et al. (2015) reveal Aspp1 as amolec-
ular guardian that protects mouse HSC
integrity in both p53-dependent and -inde-
pendent manners.
The importance of p53 in suppressing
hematopoietic malignancy is supported
by a recent finding that p53mutation pre-
cedes the diagnosis of acute myeloid leu-
kemia (AML), with therapy-related AML
resulting from clonal expansion of pre-
existing mutant-p53-containing HSC
clones (Wong et al., 2015). Importantly,
that study also showed that 50% of
elderly healthy individuals carry one
copy of mutant p53 gene, illustrating that
additional genetic alterations are required
for transformation. Therefore, there is
great interest in identifying additional
proteins that synergize with p53 to defend
against hematological malignancies.
ASPP1, a member of the evolutionarily
conserved apoptosis stimulating proteins
of p53 (ASPP) family, is one such protein.ASPP1, and the related ASPP2, binds p53
and its siblings, p63 and p73, and selec-
tively activates their pro-apoptotic func-
tions (Bergamaschi et al., 2004). Trans-
genic mouse studies have established
Aspp2 as a haploinsufficient tumor sup-
pressor and an activator of p53 (Vives
et al., 2006). ASPP1 has been identified
as an enhancer of apoptosis in human
cord blood stem cells (Milyavsky et al.,
2010), but little is known about the tumor
suppressive function of ASPP1 in adult
HSCs in vivo.
Yamashita et al. first confirmed previ-
ous findings that, after genotoxic stress,
p53 is expressed at higher levels in popu-
lations enriched for hematopoietic stem
and progenitor cells (HSPCs) compared
to those enriched for myeloid progenitor
cells, and they also observed that Aspp1
is more highly expressed in defined HSC
populations than in other hematopoietic
cell types (Yamashita et al., 2015). In
Aspp1-deficient mice, the authors found
an elevated number of white blood cells
and bone marrow myeloid mononuclearCell 17, July 2, 2015 ª2015 Elsevier Inc. 3
